You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,092,832


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,092,832 protect, and when does it expire?

Patent 8,092,832 protects FENTORA and is included in one NDA.

This patent has sixty-four patent family members in twenty-nine countries.

Summary for Patent: 8,092,832
Title:Generally linear effervescent oral fentanyl dosage form and methods of administering
Abstract: Fentanyl containing dosage forms and methods using same are described. These dosage forms include substantially less fentanyl by weight than know oral formulation and have advantages in terms of cost and side effects. These dosage forms are intended for oral administration of fentanyl across the oral mucosa.
Inventor(s): Moe; Derek (Maple Grove, MN), Agarwal; Vikas (Plymouth, MN), Habib; Walib (Crystal, MN)
Assignee: Cephalon, Inc. (Frazer, PA)
Application Number:12/955,229
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,092,832
Patent Claim Types:
see list of patent claims
Compound; Dosage form; Delivery;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a U.S. Patent: A Detailed Analysis of United States Patent 8,092,832

Introduction

When navigating the complex world of patents, understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the specifics of United States Patent 8,092,832, using it as a case study to explain the key concepts and tools involved in patent analysis.

What is a Patent?

A patent is a government grant that gives the inventor the exclusive right to make, use, and sell an invention for a specified period, usually 20 years from the filing date of the patent application[4].

The Importance of Patent Scope and Claims

Patent scope and claims are central to the patent's validity and enforceability. The scope defines the boundaries of what is protected, while the claims specify the exact invention covered by the patent. A broader scope can lead to increased licensing and litigation costs, while narrower claims may result in a shorter examination process and higher grant probability[3].

United States Patent 8,092,832: An Overview

To analyze the scope and claims of United States Patent 8,092,832, one must first identify the patent's subject matter, classification, and the specific claims made.

Subject Matter and Classification

The subject matter of a patent can be found in the abstract and the detailed description. For example, if we consider a hypothetical patent like 8,092,832, it might be classified under a specific category such as "utility patents" and further categorized into a particular class and subclass based on the USPTO's classification system[1].

Patent Claims

Patent claims are the most critical part of a patent application. They define the invention and set the boundaries of what is protected. There are two main types of claims: independent claims and dependent claims.

Independent Claims

Independent claims stand alone and define the invention without reference to other claims. They are typically broader and more general. For instance, an independent claim might read: "A method for [specific process], comprising [key steps]."

Dependent Claims

Dependent claims refer back to an independent claim and add additional limitations or features. They are narrower and more specific. An example of a dependent claim could be: "The method of claim 1, wherein [additional feature]."

Analyzing Patent Scope

Metrics for Measuring Patent Scope

Research has identified simple metrics to measure patent scope, such as independent claim length and independent claim count. These metrics can predict several correlates of patent scope, including patent maintenance payments, forward citations, and the breadth of patent classes[3].

Impact of Examination Process

The examination process at the USPTO often narrows the scope of patent claims. This is reflected in changes to claim length and claim count during the examination. Patents with narrower claims at publication tend to have a higher probability of grant and a shorter examination process[3].

Tools for Patent Analysis

Global Dossier

The Global Dossier service provided by the USPTO allows users to access the file histories of related applications from participating IP Offices. This includes the patent family, dossier, classification, and citation data, which are essential for analyzing the scope and claims of a patent[1].

Common Citation Document (CCD)

The CCD consolidates prior art cited by all participating offices for the family members of a patent application. This tool helps in visualizing search results for the same invention produced by several offices on a single page, facilitating a more comprehensive analysis of patent scope[1].

Public Search Facility and PTRCs

The USPTO Public Search Facility and Patent and Trademark Resource Centers (PTRCs) provide access to patent and trademark information. Trained staff can assist in searching and analyzing patents, including understanding the scope and claims of specific patents like 8,092,832[1].

Determining Inventorship

Correctly determining who should be listed as an inventor is crucial for the validity of a patent. Inventorship involves the conception of the idea and the reduction of the idea to practice. Errors in inventorship can lead to a patent being invalid or unenforceable if there is deceptive intent[2].

Legal and Policy Considerations

Small Claims Patent Court

There have been discussions and studies on the feasibility of a small claims patent court to address issues related to patent litigation costs and complexity. Such a court could provide a more streamlined and cost-effective way to resolve patent disputes, which could impact how patent scope and claims are enforced[5].

Key Takeaways

  • Patent Scope and Claims: These are critical components of a patent, defining what is protected and setting the boundaries of the invention.
  • Metrics for Analysis: Independent claim length and count are useful metrics for measuring patent scope.
  • Tools for Analysis: Global Dossier, CCD, Public Search Facility, and PTRCs are essential tools for analyzing patents.
  • Inventorship: Correct determination of inventorship is vital for the validity and enforceability of a patent.
  • Legal Considerations: The potential for a small claims patent court could impact patent litigation and enforcement.

FAQs

Q: What is the significance of independent claims in a patent?

A: Independent claims define the invention without reference to other claims and are typically broader and more general, setting the foundation for the patent's scope.

Q: How does the examination process affect patent claims?

A: The examination process often narrows the scope of patent claims, reflected in changes to claim length and count, which can result in a higher probability of grant and a shorter examination process.

Q: What is the Global Dossier service, and how is it useful?

A: The Global Dossier service provides access to the file histories of related applications from participating IP Offices, including the patent family, dossier, classification, and citation data, which is essential for analyzing the scope and claims of a patent.

Q: Why is correct inventorship important for a patent?

A: Correct inventorship is crucial because errors can lead to a patent being invalid or unenforceable if there is deceptive intent. It ensures the patent remains enforceable and valid.

Q: What is the proposed small claims patent court, and how might it impact patent disputes?

A: The proposed small claims patent court aims to provide a more streamlined and cost-effective way to resolve patent disputes, potentially reducing litigation costs and complexity.

Sources

  1. USPTO: Search for patents - USPTO.
  2. Oregon State University: Determining Inventorship for US Patent Applications.
  3. SSRN: Patent Claims and Patent Scope.
  4. USA.gov: U.S. Patent and Trademark Office (USPTO).
  5. ACUS: U.S. Patent Small Claims Court.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,092,832

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Cephalon FENTORA fentanyl citrate TABLET;BUCCAL, SUBLINGUAL 021947-001 Sep 25, 2006 DISCN Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Cephalon FENTORA fentanyl citrate TABLET;BUCCAL, SUBLINGUAL 021947-002 Sep 25, 2006 DISCN Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Cephalon FENTORA fentanyl citrate TABLET;BUCCAL, SUBLINGUAL 021947-003 Sep 25, 2006 DISCN Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Cephalon FENTORA fentanyl citrate TABLET;BUCCAL, SUBLINGUAL 021947-004 Sep 25, 2006 DISCN Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Cephalon FENTORA fentanyl citrate TABLET;BUCCAL, SUBLINGUAL 021947-005 Sep 25, 2006 DISCN Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,092,832

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 047999 ⤷  Subscribe
Argentina 048000 ⤷  Subscribe
Argentina 048029 ⤷  Subscribe
Argentina 098347 ⤷  Subscribe
Austria 498395 ⤷  Subscribe
Austria 500821 ⤷  Subscribe
Australia 2004311879 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.